Drug eluting ocular implant
US10813789B2 · kind B2 · utility
30Cited by
86References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 5, 2017 |
| Grant date | Oct 27, 2020 |
| Priority date | — |
| Expiry date | Oct 6, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/0092
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed herein are drug delivery devices and methods for the treatment of ocular disorders requiring targeted and controlled administration of a drug to an interior portion of the eye for reduction or prevention of symptoms of the disorder. The devices are capable of controlled release of one or more drugs and may also include structures which allow for treatment of increased intraocular pressure by permitting aqueous humor to flow out of the anterior chamber of the eye through the device.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.